Testing the lung microbiome to predict risk of frequent exacerbations in COPD

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chronic obstructive pulmonary disease (COPD) is a disease of global importance. Exacerbations, mostly due to respiratory infection, are complications that lead to significant illness. This study will characterise the communities of microbes in the lung, and use this information to predict frequency of exacerbations of COPD measured over 12 months.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $666,052.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antibiotics | chronic obstructive pulmonary disease (COPD) | clinical trial | exacerbation | microbiology